We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Topical Immunotherapy Lowers Risk of Skin Cancer

News   Mar 22, 2019 | Original story from Washington University School of Medicine in St. Louis

 
Topical Immunotherapy Lowers Risk of Skin Cancer

Washington University dermatologist Lynn Cornelius, MD, (left) conducts a skin exam with patient Robert Manchester. Manchester was a participant in a clinical trial testing the effectiveness of a topical immunotherapy against precancerous skin lesions called actinic keratoses, often found on sun-damaged skin. A three-year follow-up analysis suggests the therapy also reduces the risk that the precancerous lesions will progress to skin cancer. Credit: Washington University

 
 
 

RELATED ARTICLES

Why Tumor Cells Invade Distant Organs

News

Most cancers kill because tumor cells spread beyond the primary site to invade other organs. Now, a USC study of brain-invading breast cancer cells circulating in the blood reveals they have a molecular signature indicating specific organ preferences.

READ MORE

RNA Folding Insights Lead to New Therapeutics and Synthetic Biology Technologies

News

A research team has uncovered a new understanding of how RNA molecules act as cellular "biosensors" to monitor and respond to changes in the environment by controlling gene expression.

READ MORE

A New Way of Finding Cancer-causing Germs

News

Researchers have pioneered a new way of finding bacteria and viruses linked to cancer, by harnessing genomic data.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE